Ryan Hasselkus
Ryan Hasselkus has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Amir Bein
Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA
2 shared publications Ariel Alon
Quris Technologies LTD., 6 HaNatsiv Street, Tel Aviv, Israel
2 shared publicationsIsaac Bentwich
Quris Technologies LTD., 6 HaNatsiv Street, Tel Aviv, Israel
2 shared publicationsWei Wu
Quris Technologies INC., 38 Wareham St., Boston, USA
2 shared publicationsAlexander Watters
Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, 02115, USA
1 shared publication- Anna Herland
KTH Royal Institute of Technology
1 shared publication
Latest Publications
- Open Access
- 21 August 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Six-compound cocktail for maturation of human pluripotent stem cell-derived liver spheroids for toxicity prediction
- 21 August 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessSix-compound cocktail for maturation of human pluripotent stem cell-derived liver spheroids for toxicity prediction
- Open Access
- 4 April 2025
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 186, 118021
Multi-organ model assessment of neurotoxicity following exposure of liver spheroids to drugs
- 4 April 2025
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 186, 118021
Open AccessMulti-organ model assessment of neurotoxicity following exposure of liver spheroids to drugs
- Top Cited PapersOpen Access
- 13 June 2019
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1-12
Hypoxia-enhanced Blood-Brain Barrier Chip recapitulates human barrier function and shuttling of drugs and antibodies
The high selectivity of the human blood-brain barrier (BBB) restricts delivery of many pharmaceuticals and therapeutic antibodies to the central nervous system. Here, we describe an in vitro microfluidic organ-on-a-chip BBB model lined by induced pluripotent stem cell-derived human brain microvascular endothelium interfaced with primary human brain astrocytes and pericytes that recapitulates the high level of barrier function of the in vivo human BBB for at least one week in culture. The endothelium expresses high levels of tight junction proteins and functional efflux pumps, and it displays selective transcytosis of peptides and antibodies previously observed in vivo. Increased barrier functionality was accomplished using a developmentally-inspired induction protocol that includes a period of differentiation under hypoxic conditions. This enhanced BBB Chip may therefore represent a new in vitro tool for development and validation of delivery systems that transport drugs and therapeutic antibodies across the human BBB.
- 13 June 2019
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1-12
Top Cited PapersOpen AccessHypoxia-enhanced Blood-Brain Barrier Chip recapitulates human barrier function and shuttling of drugs and antibodies
The high selectivity of the human blood-brain barrier (BBB) restricts delivery of many pharmaceuticals and therapeutic antibodies to the central nervous system. Here, we describe an in vitro microfluidic organ-on-a-chip BBB model lined by induced pluripotent stem cell-derived human brain microvascular endothelium interfaced with primary human brain astrocytes and pericytes that recapitulates the high level of barrier function of the in vivo human BBB for at least one week in culture. The endothelium expresses high levels of tight junction proteins and functional efflux pumps, and it displays selective transcytosis of peptides and antibodies previously observed in vivo. Increased barrier functionality was accomplished using a developmentally-inspired induction protocol that includes a period of differentiation under hypoxic conditions. This enhanced BBB Chip may therefore represent a new in vitro tool for development and validation of delivery systems that transport drugs and therapeutic antibodies across the human BBB.